Valink Therapeutics

📍 Cambridge, United States🗓 Founded 2020👥 29 employees💰 Last funded Jun 2025
Biotechnology Research🌐 valinktx.com
Website LinkedIn
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications. Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United Kingdom
2
United States
1
Switzerland
1
Investor activity2021–2025 · investors recorded per year
202122022120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Valink Therapeutics?
Valink Therapeutics has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Valink Therapeutics last raise funding?
The most recent investment in Valink Therapeutics recorded on gritt.io was in June 2025.
When was Valink Therapeutics founded?
Valink Therapeutics was founded in 2020.
What industry is Valink Therapeutics in?
Valink Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Valink Therapeutics based?
Valink Therapeutics is headquartered in Cambridge, United States.